✦ LIBER ✦

Treatment of myelodysplastic syndromes with human granulocytic-macrophage colony stimulating factor (GM-CSF) or GM-CSF combined with low-dose cytosine arabinoside

✍ Scribed by T. Economopoulos; E. Papageorgiou; N. Stathakis; N. Asprou; P. Karmas; J. Dervenoulas; H. Bouronikou; G. Chalevelakis; S. Raptis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of myelodysplastic syndromes w

✍ T. Economopoulos; E. Papageorgiou; N. Asprou; P. Karmas; J. Dervenoulas; H. Bour 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Treatment of high risk myelodysplastic s

✍ Theofanis Economopoulos; Efstathios Papageorgiou; Nicholas Stathakis; Maria Cons 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 605 KB

Treatment of “high risk” myelodysplastic

✍ T. Economopoulos; E. Papageorgiou; A. Parharidou; M. Constantinidou; J. Dervenou 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Effects of low doses of recombinant huma

✍ Elihu H. Estey; Razelle Kurzrock; Moshe Talpaz; Kenneth B. McCredie; Susan O'Bri 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB

Improvement of pneumonia and arthritis i

✍ Lübbe, A. S. ;Schwella, N. ;Riess, H. ;Huhn, D. 📂 Article 📅 1990 🏛 Springer-Verlag ⚖ 198 KB

Granulocyte-Macrophage colony stimulatin

✍ Paul S. Frenette; Jane F. Desforges; David P. Schenkein; Arthur Rabson; Christop 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 783 KB